MDM2 and cancer: It is well accepted that USP7, the most studied deubiquitinating enzyme, attenuates the level of tumor suppressor p53 by protecting MDM2 and MDMX from ubiquitination-mediated proteasome degradation during cancer progression [11, 37–39].